Background Significant paravalvular leak (PVL) after surgical valve replacement can result
in intractable congestive heart failure and hemolytic anemia. Because repeat surgery is …

Percutaneous paravalvular leak (PVL) closure has emerged as a feasible alternative to redo
valve surgery. However, comparative data on percutaneous and surgical treatment of PVL …

Objectives: This study sought to assess the relative merit of surgical correction (SC) versus
transcatheter reduction on long-term outcomes in patients with significant paravalvular leak …

Paravalvular leak (PVL) is a serious complication after surgical valve replacement or after
transcatheter aortic valve replacement. Approximately 1–5% of PVLs can lead to serious …

Background Significant paravalvular leak (PVL) after prosthetic replacement can result in
hemolysis and/or congestive heart failure (CHF). Percutaneous PVL reduction (PPVR) …

Objectives: The aim of this study was to compare outcomes of transcatheter intervention (TI)
versus surgical intervention (SI) for paravalvular leak (PVL). Background: Data comparing …

Paravalvular leak (PVL) is an uncommon yet serious complication associated with the
implantation of mechanical or bioprosthetic surgical valves and more recently recognized …

Objectives Paravalvular leaks (PVL) occur in up to 17% of all surgically implanted prosthetic
valves. Re-operation is associated with high morbidity and mortality. Transcatheter closure …

Background Percutaneous closure of paravalvular leak (PVL) has emerged as an alternative
treatment. Predictors of survival and procedural success are unknown. Objectives To review …

Serious paravalvular leakage occurs in 1–5% of patients who have undergone surgical
cardiac valve replacement procedures. Clinical manifestations include hemolysis, heart …